EDIT

#3270
Editas Medicine, Inc. Common Stock
3.39 USD
+5.94%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
3.39
3.39
년간 변동
1.23
4.54
일일 변동
+5.94%
월간 변동
+37.80%
6달 변화
-7.88%
년간 변동율
+160.77%
이전 종가
3.20
Open
3.39
Bid
Ask
Low
3.39
High
3.39
양
60
Open full chart

Financials

Overview 성명 Statistics
Quarterly Annual
  • Market Capitalization 331.79 M
  • Employee 87
  • Founded N/A
  • CEO N/A
  • Website www.editasmedicine.com
  • Headquarter Delaware, United States
  • FIGI BBG005MX5GZ2
  • Industry Technology
총매출
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.14
Price to sales ratio
4.49

Editas Medicine Inc

Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado.

뉴스